Anuh Pharma Ltd reports H1 FY27 revenue of ₹379.05 crore and PAT growth of 42.25% in investor presentation
- H1 FY27 EBITDA was ₹36.92 crore, with a 9.74% margin versus 7.13% a year earlier.
- Q2 FY27 revenue was ₹185.24 crore; EBITDA was ₹17.55 crore (9.47% margin) and PAT was ₹11.21 crore.
- Presentation cites production growth, capacity expansion and plans to rebuild exports.
